MOH — authorised 5 November 2015
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: likely_approved
MOH authorised Vemlidy on 5 November 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 5 November 2015.
GILEAD SCIENCES INC holds the Israeli marketing authorisation.